Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Optical Disorders Drugs 78
Oncology Drugs 76
Optical 75
Immune Disorders Drugs 68
Cardiovascular Drugs 45
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Biotechnology 28
Genomics 28
Clinical Trials 27
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Diagnostics 8
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Therapeutic Area 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

671 Results (Page 10 of 34)
- Relevance
  Sort by

Asia Pacific Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027

 Report
March 2022
71 Pages
Asia Pacific

From

€1365EUR$1,500USD£1,170GBP

Europe Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027

 Report
March 2022
71 Pages
Europe

From

€1365EUR$1,500USD£1,170GBP

North America Diabetic Retinopathy Market Size, Share & Industry Trends Analysis Report By Type, By Treatment Type, By Country and Growth Forecast, 2021-2027

 Report
March 2022
64 Pages
North America

From

€1365EUR$1,500USD£1,170GBP

Retinal Vein Occlusion - Market Insight, Epidemiology and Market Forecast - 2034

 Report
January 2024
174 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

COVID-19 Current Therapy Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
69 Pages
Global

From

€3185EUR$3,500USD£2,731GBP

Retinopathy of Prematurity - Market Insight, Epidemiology And Market Forecast - 2032

 Report
November 2023
113 Pages
Global

From

€6826EUR$7,500USD£5,852GBP

Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3777EUR$4,150USD£3,238GBP

Juvenile Idiopathic arthritis (JIA) - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1820EUR$2,000USD£1,560GBP

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

 Report
January 2024
120 Pages
Global

From

€7235EUR$7,950USD£6,203GBP

Macular Degeneration Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
December 2023
250 Pages
Global

€4546EUR$4,995USD£3,897GBP

Atopic Dermatitis (Atopic Eczema) (Dermatology) - Drugs In Development, 2021

 Drug Pipelines
June 2021
847 Pages
Global

From

€2275EUR$2,500USD£1,951GBP

Beta Nerve Growth Factor (Beta NGF or NGF) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
February 2022
50 Pages
Global

From

€3185EUR$3,500USD£2,731GBP

Rheumatoid Arthritis Therapeutics Market Report and Forecast 2024-2032

 Report
May 2024
160 Pages
Global

From

€4504EUR$4,949USD£3,861GBP

Oligonucleotide Therapy Market Report 2025

 Report
March 2025
250 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Oncolytic Virus Therapy Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

Atopic Eczema Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
87 Pages
Global

From

€3500EUR$4,120USD£3,106GBP

Coronavirus Disease 2019 (COVID-19) Vaccines and Drugs Contract Pharmaceutical Development and Manufacturing Relationships

 Report
September 2021
52 Pages
Global

From

€4546EUR$4,995USD£3,897GBP

Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
119 Pages
Global

From

€4095EUR$4,500USD£3,511GBP

Diagnostic Enzyme Market Report 2025

 Report
April 2025
250 Pages
Global

From

€4086EUR$4,490USD£3,503GBP

671 Results (Page 10 of 34)
- 1
- 8
- 9
- 10
- 11
- 12

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.